pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-548al |
Genomic Coordinates | chr11: 74399237 - 74399333 |
Description | Homo sapiens miR-548al stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-548al | |||||||||||||||||||||||||||||||||||
Sequence | 65| AACGGCAAUGACUUUUGUACCA |86 | |||||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
|||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||||
Putative Targets |
Gene Information | ||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | THUMPD3 | |||||||||||||||||||||||||||||||||||||||||||||
Synonyms | - | |||||||||||||||||||||||||||||||||||||||||||||
Description | THUMP domain containing 3 | |||||||||||||||||||||||||||||||||||||||||||||
Transcript | NM_001114092 | |||||||||||||||||||||||||||||||||||||||||||||
Other Transcripts | NM_015453 | |||||||||||||||||||||||||||||||||||||||||||||
Expression | ||||||||||||||||||||||||||||||||||||||||||||||
Putative miRNA Targets on THUMPD3 | ||||||||||||||||||||||||||||||||||||||||||||||
3'UTR of THUMPD3 (miRNA target sites are highlighted) |
>THUMPD3|NM_001114092|3'UTR 1 AGATGACTAATAGTACTTGTACTTCCCACCACTGGAAATGTTAGCATAAAAGAACTTGGAGAGGAAAAAAGTATTAACAA 81 AACTGCAGTCTGCACTCTTTAAACCTGTTTAAGGCTCTTCATCCTGGTTAGCAAAAGGTGTGAATGTAATGTGATGGAAT 161 TTAAAAGTTTTATGAGACCAGGCACAGTGGCTCACGACTGTAATTCCAGCAGTTTAGGAAGCCGAAGTGTGCAGATCACC 241 TGAGGTCCGGAGACCAGCCTGGCCAACATGGTGAAACCCTGTCTCTACTAGAAATACAAAAATTAGCCAGGTGTGGTGGC 321 GGGCGCCTGTAATCCCAACTACTCAGGAGGCTGAGGCTAGAGAATCACTTGAACCCAGCAGGCGGAGGTTGCGGTGAGTC 401 GAGATCACGCCATTGCACTCCAGCCTGTGCGACAAGAGCGAAACTCTGTCTCAAAAAGATTTTATAAGAAAGCAGAGCTT 481 TTCCTTGAAGCTCTTTTGAAGTGGTAGCTTAATTAGTATTTTGTTGAAAATACTTTAAAGATGCCTAGTGAAAAGCCTAC 561 TAAAGTGCTGTGAGATTGGGGTTTAGAACATTTTATTTTCAGGCTTTATGGCCTATTTTCCATTGTGTCAAGTGCAAAAC 641 TACCCTGGCCCAAAGGAAGGGCAGAGAACATAATTACATCTTAGGCCACATTTCATTCTTTGCAGCTTTGCTAATCCAGT 721 TGCTCAAGTTCTTTACCTCAACCTGAAGGAATGAAGCATTATTACATTTTGTGAATGGTGTTCAGCCTATAAGACGAAGT 801 CTCACAAGACCTATAGGAAAGTTTACCATCTGCCTTAAATATTAAAATATCCATCTGTTATTCACATTAATACACAGAAT 881 GAAAATAGAGGTCTAGGAATTATCAAAGGTACTGCAAAAATACTGTATAGAACTTATTTGTAAATAGCACATACATTGAT 961 AGATGGGGTGTGGGACCAACAAACCAAATTAAAAGAAATTGTTTTTCTTTCAGTACACTAAGGTGTGTGTTTTCAAAACC 1041 AAACACAAACCTGTCAAGAGTATTTGTTGGCTAGTTTCTTAAAAGGCCAAGAGAAAAAAAATGATATATCTTTGGAAAAC 1121 TTTTAATTTGGGAGTTATGTGAGTTGTTACTTTCTCCTGGATCACGATTCACATTTAATTGCTTTTCCAGTTGCAACAAG 1201 TCCTTCTTGAGAGTTTTGTGGAAAATGGTGCTTCCCTGGAACAAAGAGTAGTTGAGGTTTTTTTGTGGAACTCATCATAG 1281 TATTGTTTATTTTGGAGCCTCTGGCTGCAATCAGTATAGATTTTCAGTATCCTATTAGTATTATAATAGTACTCCTCTTA 1361 ATACTTTCTGATGTCTCCATTGAGAATAAAAGGACACAATACTTTTGAAAGAAGAGTTCACATTAGCAGCACAGCCAGCA 1441 ATCCTCATCTGGTTTCTCTGATCTCCTACCCCACACTTCATAATGAATGGGAAATAAGATGTTTATGAAGGTTTTATATC 1521 CTAGACTGGCCTTTTTACCACTATCAGAATTCACAGCTGCTTTGTTTATGGGCCGAACACAAAACTTTTCACCTGATGGG 1601 AGAAACCATTTAAACCTCAAATTAAGCAACCCACAGAACCAGGAAGTTCAAGGACCATGTCTGTTTTCACCACGATGTCT 1681 TTCCCCACCCCCCCACCCCCCACTCCACCCCCCACTAAGGGCAGGGTATTGTATCTGCCAGACTGGGTATTTGTTGAACA 1761 AGCGAGTATTTTCGCCTATTAGCTTAGTTTTTAAGGAAATCATTTTTTACTTGATTCATCATAGCTTTAATTCTATTACA 1841 TACTACAATAAAAATTTGACAAGACTGATACAAATATGTAGTGGGCAATAGTTTGCCGTCTTCTTCCCTAGTATGGTGTT 1921 TTTCAATCTGGTGACTAGAATAGGCAGTGGGCTATAAGCAGGATTCATAAGGCCTGGAGCTGAGTTATATGTGACACTGC 2001 CACCTATTCATTGTGTGACCTTGGTTTTAACCTTCAAAGTGGGTCTCCTGGACTAAAAGAATGTGAAAAGATGGGGAAAT 2081 AAATCTGTAATCTGAACATGGAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
|||||||||||||||||||||||||||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
|||||||||||||||||||||||||||||||||||||||||||||
DRVs in gene 3'UTRs |
|
|||||||||||||||||||||||||||||||||||||||||||||
SNPs in gene 3'UTRs |
|
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | hESCs (WA-09) | ||||||
Disease | 25917.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine
... - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al. - Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
|
CLIP-seq Support 1 for dataset SRR359787 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | hESCs (WA-09) / 4-thiouridine, RNase T1 |
Location of target site | ENST00000345094.3 | 3UTR | AUAGUUUGCCGUCUUCUUCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22012620 / SRX103431 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
15 hsa-miR-548al Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT100248 | MRPS18B | mitochondrial ribosomal protein S18B | ![]() |
![]() |
2 | 2 | ||||||
MIRT466864 | STX6 | syntaxin 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT472971 | MSANTD3 | Myb/SANT DNA binding domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT477531 | EIF4G2 | eukaryotic translation initiation factor 4 gamma 2 | ![]() |
![]() |
2 | 5 | ||||||
MIRT483200 | PIP4K2A | phosphatidylinositol-5-phosphate 4-kinase type 2 alpha | ![]() |
![]() |
2 | 2 | ||||||
MIRT496727 | NKD2 | naked cuticle homolog 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT504947 | ZNRF2 | zinc and ring finger 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT529248 | TRIM4 | tripartite motif containing 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT529477 | THUMPD3 | THUMP domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT576335 | Rapgefl1 | Rap guanine nucleotide exchange factor (GEF)-like 1 | ![]() |
![]() |
2 | 5 | ||||||
MIRT607473 | RAPGEFL1 | Rap guanine nucleotide exchange factor like 1 | ![]() |
![]() |
2 | 7 | ||||||
MIRT629228 | FAM186A | family with sequence similarity 186 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT651501 | WT1 | Wilms tumor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT662296 | SLC29A4 | solute carrier family 29 member 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT688897 | C1GALT1 | core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 | ![]() |
![]() |
2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|